UKCO 2024 Sponsors

We would like to thank our Congress Sponsors


Boehringer Ingelheim Ltc Boehringer Ingelheim Ltd has provided funding for this independent ECR event and had no input or control over the agenda, attendees or choice of speakers.
J&J Medtech J&J/Ethicon have contributed funding towards this event. Sponsors have had no input into the agenda or the selection of speakers with the exception of any sponsored presentations which are clearly indicated.
Gold
Novo Nordisk Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes, obesity and other serious chronic diseases.

We aim to be the leading force in the science behind obesity, and we do so by pioneering scientific breakthroughs, expanding access to our medicines and working with scientific and medical experts to increase awareness of obesity as a serious and chronic disease.

Nearly 100 years of expertise in treating diabetes has given Novo Nordisk the knowledge to pursue innovative approaches to fighting obesity. We aim to be the leading force in the science behind obesity, and we do so by pioneering scientific breakthroughs, expanding access to our medicines and working with scientific and medical experts to increase awareness of obesity as a serious and chronic disease.

Novo Nordisk employs about 45,800 people in 80 countries and markets its products in around 170 countries.
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transform the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases by rapidly advancing care and precision medicines addressing the root cause. Our science is dedicated to the understanding of hyperphagia and severe obesity caused by genetic variants leading to an impaired MC4R pathway. For more information about the science and our solutions, please visit our website http://www.path4hcps.com
Bronze
Echosens A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4 200+ peer-reviewed publications and 180+ international guidelines. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.


Exhibitors

You will also be able to meet colleagues from the following organisations who will be exhibiting at UKCO 2024.


Coming soon ....



Charity Exhibitors

You will also be able to meet representatives from the following organisations who will be exhibiting.


Coming soon ....


Thank you for our sponsors who have supported the Association for the Study of Obesity (ASO) towards covering the costs of UKCO 2024. All sponsors have had no influence over the creation, development or content of the programme, apart from the Industry Led Symposium.

The UK Congress on Obesity has been instigated and organised by ASO. Sponsors have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated. View a full list of sponsors.